Nasus Pharma Ltd. (NSRX)
NYSEAMERICAN: NSRX · Real-Time Price · USD
3.350
-0.200 (-5.63%)
Sep 10, 2026, 4:00 PM EDT - Market closed
Nasus Pharma Market Cap
Nasus Pharma has a market cap or net worth of $39.24 million as of September 10, 2026. Its market cap has decreased by -45.86% in one year.
Market Cap
39.24M
Enterprise Value
27.53M
1-Year Change
-45.86%
Ranking
Category
Stock Price
$3.35
ChartMarket Cap Chart
Since the IPO on August 14, 2025, Nasus Pharma's market cap has decreased from $72.08M to $39.24M, a decrease of -45.56%. That is a compound annual growth rate of -43.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2026 | 39.24M | -52.66% |
| Dec 31, 2025 | 82.90M | 15.01% |
| Aug 14, 2025 | 72.08M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pfizer | 158.39B |
| Bristol-Myers Squibb Company | 132.14B |
| Sanofi | 104.09B |
| GSK plc | 97.52B |
| Biogen | 31.40B |
| Grifols | 6.94B |
| Organon & Co. | 3.61B |
| Amarin Corporation | 301.00M |